RedPath Integrated Pathology
Healthcare Services · Pennsylvania, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2515 Liberty Ave, Pittsburgh, Pennsylvan...Phone Number
(412) 224-6100Website
www.npcnregistry.comRevenue
$16.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About RedPath Integrated Pathology
The National Pancreatic Cyst Registry is a prospective study focusing on Integrated Molecular Pathology (IMP) to predict the malignancy of pancreatic cysts. It collaborates with leading academic medical centers and community-based practices to assess the performance characteristics and clinical utility of IMP alongside traditional tests. The study specifically evaluates the efficacy of PathFinderTG (PancraGEN) in risk-stratifying patients based on malignancy potential. Sponsored in part by RedPath Integrated Pathology, Inc. (Interpace Diagnostics), the registry aims to advance understanding and management of pancreatic cysts.Explore more
RedPath Integrated Pathology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is RedPath Integrated Pathology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
RedPath Integrated Pathology, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if RedPath Integrated Pathology is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at RedPath Integrated Pathology
Check if RedPath Integrated Pathology has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when RedPath Integrated Pathology launches new products
Earning: See what the market has to say on RedPath Integrated Pathology recently announced quarterly report
Click to see if RedPath Integrated Pathology had a recent Job posting/layoffs
Funding: Get notified immidiatlly once RedPath Integrated Pathology has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at RedPath Integrated Pathology
Find more new buyers
Compare Similar Companies to RedPath Integrated Pathology
Compare insights from companies similar to RedPath Integrated Pathology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
RedPath Integrated Pathology is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
RedPath Integrated Pathology is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about RedPath Integrated Pathology.
RedPath Integrated Pathology Tech Stack
A closer look at the technologies used by RedPath Integrated Pathology
See more technologies
Top Healthcare Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding RedPath Integrated Pathology
Sign Up For FreeTo access detailed company insights
The National Pancreatic Cyst Registry is a prospective study focusing on Integrated Molecular Pathology (IMP) to predict the malignancy of pancreatic cysts. It collaborates with leading academic medical centers and community-based practices to assess the performance characteristics and clinical utility of IMP alongside traditional tests. The study... Read More
